? This COBRE is designed to develop the research careers of a series of promising junior investigators in the field of Cancer Genetics. Their careers will be developed utilizing a strong core of research mentors who will help craft a plan for the development of each investigator, and provide advice and encouragement to those investigators. The five projects in this COBRE focus on two critical, overlapping areas in cancer genetics, genetic instability and gene regulation. An internal advisory committee composed of mentors and other scientists with extremely strong research and mentoring records, along with a prominent board of external advisors with outstanding research careers and track records of career development for junior scientists, will participate not only in the guidance, but also the evaluation of progress of the junior investigators. Besides the strong mentoring program, career development will involve a series of program meetings, exposure to didactic grant-writing sessions, mini-symposia, and seminars to develop a highly collaborative environment for both the junior faculty, as well as other members of the COBRE and the Cancer Genetics Research Program under the auspices of the Louisiana Cancer Research Consortium (LCRC). The LCRC is a joint effort of Tulane University and the Louisiana State University Health Sciences Center in New Orleans to develop a Cancer Consortium. The Consortium is funded by a long-term State of Louisiana commitment, with the goal of obtaining NCI-designation for a Cancer Center in New Orleans. The Consortium is providing funds for recruitment of at least 6 new investigators for the Cancer Genetics Research Program in the next two years, as well as providing a new building that will allow investigators from both Tulane and LSUHSC to share common space designed around this Program. This COBRE will represent the ideal centerpiece to develop successful and productive careers of promising junior investigators who are valuable members of the Cancer Genetics Research Program, in a manner centered on collaboration and faculty development, resulting in strong growth and establishing long-term success of both the COBRE and the Cancer Genetics Research Program. ? ?

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-5 (01))
Program Officer
Gorospe, Rafael
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Tulane University
Public Health & Prev Medicine
Schools of Public Health
New Orleans
United States
Zip Code
Ade, Catherine M; Derbes, Rebecca S; Wagstaff, Bradley J et al. (2018) Evaluating different DNA binding domains to modulate L1 ORF2p-driven site-specific retrotransposition events in human cells. Gene 642:188-198
Hodel, Karl P; de Borja, Richard; Henninger, Erin E et al. (2018) Explosive mutation accumulation triggered by heterozygous human Pol ? proofreading-deficiency is driven by suppression of mismatch repair. Elife 7:
Gopalakrishnan, Anusha M; Aly, Ahmed S I; Aravind, L et al. (2017) Multifunctional Involvement of a C2H2 Zinc Finger Protein (PbZfp) in Malaria Transmission, Histone Modification, and Susceptibility to DNA Damage Response. MBio 8:
Ma, Lin; Li, Jingwu; Nie, Qiang et al. (2017) Organoid culture of human prostate cancer cell lines LNCaP and C4-2B. Am J Clin Exp Urol 5:25-33
Yang, Lingyun; Huang, Feng; Mei, Jiandong et al. (2017) Posttranscriptional Control of PD-L1 Expression by 17?-Estradiol via PI3K/Akt Signaling Pathway in ER?-Positive Cancer Cell Lines. Int J Gynecol Cancer 27:196-205
Zhang, Qiuyang; Liu, Sen; Ge, Dongxia et al. (2017) Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse Model. Prostate 77:888-899
Servant, Geraldine; Streva, Vincent A; Derbes, Rebecca S et al. (2017) The Nucleotide Excision Repair Pathway Limits L1 Retrotransposition. Genetics 205:139-153
Martin, Elizabeth C; Conger, Adrienne K; Yan, Thomas J et al. (2017) MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance. FEBS Lett 591:382-392
Wu, Victor J; Pang, Darren; Tang, Wendell W et al. (2017) Obesity, age, ethnicity, and clinical features of prostate cancer patients. Am J Clin Exp Urol 5:1-9
Wang, Xun; Yang, Lingyun; Huang, Feng et al. (2017) Inflammatory cytokines IL-17 and TNF-? up-regulate PD-L1 expression in human prostate and colon cancer cells. Immunol Lett 184:7-14

Showing the most recent 10 out of 157 publications